Marimed (MRMD) EBT Margin (2011 - 2026)

Marimed (MRMD) has 16 years of EBT Margin data on file, last reported at 2.83% in Q1 2026.

• On a quarterly basis, EBT Margin rose 416.0% year-over-year to 2.83% in Q1 2026; TTM through Mar 2026 was 5.7%, a 122.0% decrease from a year earlier, with the FY2025 full-year figure at 6.8%, down 409.0% from the prior year.
• EBT Margin for Q1 2026 stood at 2.83%, up from 17.59% in the prior quarter.
• Over the last five years, EBT Margin for MRMD reached as high as 25.26% in Q1 2022 and fell as low as 24.76% in Q4 2023.
• Historically, EBT Margin has averaged 0.22% across 5 years, with a median of 0.45% in 2025.
• Across the five-year window, EBT Margin slumped 3245 bps in 2023 and soared 1624 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 7.69% in 2022, then plunged by 422 bps to 24.76% in 2023, then surged by 66 bps to 8.51% in 2024, then tumbled by 107 bps to 17.59% in 2025, then surged by 84 bps to 2.83% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 2.83% in Q1 2026, 17.59% in Q4 2025, and 0.45% in Q3 2025.